<VariationArchive VariationID="2013574" VariationName="NM_000216.4(ANOS1):c.1499_1500del (p.Val500fs)" VariationType="Deletion" Accession="VCV002013574" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2067657" VariationID="2013574">
      <GeneList>
        <Gene Symbol="ANOS1" FullName="anosmin 1" GeneID="3730" HGNC_ID="HGNC:6211" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="8528874" stop="8732137" display_start="8528874" display_stop="8732137" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="8496914" stop="8700226" display_start="8496914" display_stop="8700226" Strand="-" />
          </Location>
          <OMIM>300836</OMIM>
          <Haploinsufficiency last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANOS1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANOS1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000216.4(ANOS1):c.1499_1500del (p.Val500fs)</Name>
      <CanonicalSPDI>NC_000023.11:8536891:CAC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="8536892" stop="8536893" display_start="8536892" display_stop="8536893" variantLength="2" positionVCF="8536891" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="8504933" stop="8504934" display_start="8504933" display_stop="8504934" variantLength="2" positionVCF="8504932" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>V500fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.8504934_8504935del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.8504934_8504935del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.8536893_8536894del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.8536893_8536894del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007088.2" sequenceAccession="NG_007088" sequenceVersion="2" change="g.200294_200295del">
            <Expression>NG_007088.2:g.200294_200295del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000216.4" sequenceAccession="NM_000216" sequenceVersion="4" change="c.1499_1500del" MANESelect="true">
            <Expression>NM_000216.4:c.1499_1500del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000207.2" sequenceAccession="NP_000207" sequenceVersion="2" change="p.Val500fs">
            <Expression>NP_000207.2:p.Val500fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000216.4(ANOS1):c.1499_1500del (p.Val500fs) AND Hypogonadotropic hypogonadism 1 with or without anosmia" Accession="RCV002834770" Version="2">
        <ClassifiedConditionList TraitSetID="2830">
          <ClassifiedCondition DB="MedGen" ID="C1563719">Hypogonadotropic hypogonadism 1 with or without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11297579</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8504298</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2830" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6234" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome, type 1, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSPLASIA OLFACTOGENITALIS OF DE MORSIER</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="300836.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 1 with or without anosmia</ElementValue>
                <XRef ID="MONDO:0010635" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome 1</ElementValue>
                <XRef ID="Kallmann+syndrome%2C+type+1%2C+X-linked/3949" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HHA</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KMS</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HH1</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KAL1</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000508943" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556730" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511585" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529045" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558347" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556729" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569425" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3071" />
                <XRef ID="3071" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ANOSMIC HYPOGONADISM</Attribute>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="478" DB="Orphanet" />
              <XRef ID="C1563719" DB="MedGen" />
              <XRef ID="MONDO:0010635" DB="MONDO" />
              <XRef Type="MIM" ID="308700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5901233" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17024402|MedGen:C1563719" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003218436" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8504298</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11297579</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with ANOS1-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val500Aspfs*27) in the ANOS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANOS1 are known to be pathogenic (PMID: 8504298, 11297579).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANOS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.8504933_8504934del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1563719" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5901233" TraitType="Disease" MappingType="XRef" MappingValue="C1563719" MappingRef="MedGen">
        <MedGen CUI="C1563719" Name="Hypogonadotropic hypogonadism 1 with or without anosmia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

